Search Results 931-940 of 17401 for alopecia

  1. Mayo Clinic

    About this Site · Contact Us · Locations · Health Information Policy · Medicare Accountable Care Organization (ACO) · Media Requests · News Network · Price ...

  2. Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors - Mayo Clinic

    Patients should have resolution of any toxic effects of prior therapy (except alopecia and fatigue) to National Cancer Institute (NCI) CTCAE, version 5.0, grade ...

  3. A Study to Evaluate AMG 701 in Subjects with Multiple Myeloma - Mayo Clinic

    ... alopecia or toxicities from prior anticancer therapy that are considered irreversible (defined as having been present and stable for > 4 weeks) which may be ...

  4. A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme - Mayo Clinic

    The primary objective of this study is to assess the effect of berubicin compared with lomustine on overall survival (OS) in adult patients with Glioblastoma ...

  5. https://www.mayoclinic.org/chinese_patient_consumer_video.xml

  6. Brightline-4: A study to test how well brigimadlin is tolerated by people with a type of cancer called dedifferentiated liposarcoma - Mayo Clinic

    All toxicities related to previous anticancer therapies have resolved to CTCAE Grade ≤ 1 prior to study treatment administration (except for alopecia and ...

  7. Breast calcifications - Mayo Clinic

    Sign up for free and receive the latest on breast cancer treatment, care and management. I would like to learn more about:.

  8. Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Toxicities of prior therapy (excepting alopecia) should be resolved to less than or equal to grade 1 as per National Cancer Institute-Common Terminology ...

  9. Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas - Mayo Clinic

    All treatment-related toxicity resolved to Grade 1 or baseline (alopecia excepted);; ANC ≥ 1,500/µL;; Platelets ≥ 100,000/µL;; Hgb ≥ 9.0 g/dL (in the ...

  10. Mayo Clinic

    Parking for patients and visitors is available in an underground parking ramp across from the Mayo Clinic Building. The parking ramp has direct access to ...